T-cell antigenic sites tend to be amphipathic structures.
about
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine developmentAmphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravisMolecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virusPatients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 moleculesAn epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like proteinVaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalkAmphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitisEpiJen: a server for multistep T cell epitope prediction.Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.Human cartilage proteoglycans as T cell autoantigensAn immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.Murine T-cell response to native and recombinant protein antigens of Rickettsia tsutsugamushi.Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin.Immunodominant regions for T helper-cell sensitization on the human nicotinic receptor alpha subunit in myasthenia gravis.Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.Periodic variation in side-chain polarities of T-cell antigenic peptides correlates with their structure and activityEpitopes on the beta subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subjects.Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10.Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunitCharacterization of antigen association with accessory cells: specific removal of processed antigens from the cell surface by phospholipases.Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.Site-directed mutagenesis of an HLA-A3 gene identifies amino acid 152 as crucial for major-histocompatibility-complex-restricted and alloreactive cytotoxic-T-lymphocyte recognition.Immuno-informatics: Mining genomes for vaccine components.Synthetic peptides as cancer vaccines.Structure of the RESA gene of Plasmodium falciparum.Emerging vaccine informatics.Immunogenicity of synthetic peptides of Haemophilus influenzae type b outer membrane protein P1.Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin.A sequence pattern common to T cell epitopesIdentification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells.Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine developmentEndogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.Nonoverlapping T and B cell determinants on an hepatitis B surface antigen pre-S(2) region synthetic peptide.
P2860
Q21328677-82A8D129-A615-435C-99CA-CE7D1C430D3EQ24561626-719E8C2E-4A46-4EB9-885B-211862F9ED9FQ24621002-EAE7D88E-3009-48BD-8B87-94010B556129Q27478466-8B84D9B8-0B3C-49EC-B4E7-A7395FE3A47EQ27485984-99808755-0AC5-4A82-AA09-E2C3B0DD3363Q27486239-C0DFB647-5A9F-4C2A-BB7D-97FDBF2CD8FEQ27486872-1B779BB2-5692-4E92-86F9-3C4C10181962Q28347677-5730CE98-5399-4E04-B4AA-D6632E610296Q33236277-3AE2F5AD-0D1A-464E-B223-1D487E613D3CQ33541540-4A9EA157-CD5F-4928-AE36-6C4CF2D7B0ABQ33565109-EB8B4837-48FA-4A0A-A2C6-F355A2F145E7Q33570776-4BACF8CA-8521-4710-BB09-4F5E715B5636Q33594703-6D9CD720-C652-470F-935A-518FF570AE12Q33829395-E55DA70E-7551-4F75-AA11-918403CCA6DFQ33831379-B82B8FF9-781D-4A29-8B8F-822CAE5C8FC1Q33854050-627A5367-4073-4CB1-9815-C61B740CC211Q33933546-D6653F60-CC97-4218-8430-6C86B52C5FFDQ33973345-271B9EC7-ACC7-47D0-BC68-D807DFC17B5DQ34131386-5A3DC1F5-139C-47F8-8C9E-7AADC81ABC65Q34145568-53F89605-C503-41CC-910C-4B62167E19B6Q34197974-54075189-97C9-48B0-804F-B748477940BAQ34225571-3044E412-BA4C-45D8-8553-0086F19496D4Q34323839-0E68A8E0-CFBB-4CC7-812C-4DFFDED965EFQ34334721-DD611690-1938-4EBA-85D9-1CF666BAA011Q34589680-DDCCBA45-085C-490D-9709-B26B7ADA43ABQ34632476-82317EA7-62CD-42F9-9345-CD9D15EB8374Q34640420-E871BFCE-5A00-4E78-8BC6-3FC086224886Q34640674-7E7D9E4F-A613-433B-97F5-F8F6276AB582Q34687622-805A4D4C-3D49-4D7A-BF44-2EE86FC25324Q34972916-E65AD2FB-D876-4274-91D4-54B6C4853F5DQ35055418-3FF55D90-1F32-439D-A179-3655C39E123CQ35100809-603B7141-F68A-4A4B-AD06-CD76D5130722Q35440720-2C31F88B-4F58-4C4C-86AC-8B08D59DD9E1Q35593962-F496AC9D-D62C-4BC4-8AA9-3736B950EC52Q35798318-1132F873-302C-47C0-B15D-1039C30B89B1Q35973055-9D807BE9-D069-4B27-8161-9C507F3FB876Q36230311-1B90145E-5122-488A-949E-F0BD5D359E48Q36231451-60C7AF7A-511F-4915-B1AD-517F2B8FE221Q36232156-CC7ECF8E-EA8F-4E26-A6F8-58891F5FFE97Q36352272-6D55A4EC-0E45-4E6D-BCD6-1526B7F9DF65
P2860
T-cell antigenic sites tend to be amphipathic structures.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T-cell antigenic sites tend to be amphipathic structures.
@en
T-cell antigenic sites tend to be amphipathic structures.
@nl
type
label
T-cell antigenic sites tend to be amphipathic structures.
@en
T-cell antigenic sites tend to be amphipathic structures.
@nl
prefLabel
T-cell antigenic sites tend to be amphipathic structures.
@en
T-cell antigenic sites tend to be amphipathic structures.
@nl
P2860
P356
P1476
T-cell antigenic sites tend to be amphipathic structures.
@en
P2093
Berzofsky JA
P2860
P304
P356
10.1073/PNAS.82.20.7048
P407
P577
1985-10-01T00:00:00Z